AKASA

Private

South San Francisco, CaliforniaHealthcare & Life Scienceshttps://akasa.com/

Last Round

Early Funding

Jun 18, 2024

Est. Valuation

$94.43M

Total Funding Raised

$325M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

AKASA is a healthcare technology company that provides generative AI solutions to streamline revenue cycle management for health systems.

Sector

Healthcare & Life Sciences

Verticals

Revenue Cycle, Healthcare Analytics, Workflow Automation, Medical AI

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS, Services & Consulting, Revenue Share

AI Layer

Application

Keywords

revenue cycle managementRCMhealthcare automationAI revenue cycleclaims processingprior authorizationmedical billing automationhealthcare AIEHR integrationrevenue cycle bothealthcare SaaSclinical documentation improvementCDIdenials managementautonomous healthcare

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AKASA Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

AKASA Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Early Funding	Jun 18, 2024
Series B	Mar 23, 2021
Series A	Jun 10, 2020
Seed	Dec 20, 2018

View all Funding Rounds

Key People

Founding team and executive leadership

Varun Ganapathi

Co-founder And Chief Technology Officer

Founding Team

Cory Costley

Chief Product Officer

Executive Team

AKASA Investors

Notable investors and investment history

Investor	Rounds
Andreessen Horowitz	Early Funding, Series C, Series B, Seed, Series A
Bond Capital	Series B
Costanoa Ventures	Early Funding, Seed, Series C, Series B, Series A
Coatue Management	Series C
BOND	Series B

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Mar 22, 2026
CEO ranked among Top 50 Healthcare Technology CEOs.
Mar 22, 2026
Certified for 6 consecutive years.

View all signals

AKASA Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

AKASA Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about AKASA's valuation, stock price, and market status.

Firmographic Details

HeadquartersSouth San Francisco, California

Employee Range238

Year Founded2018

Last FundingJun 18, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.